BioSpace News Archive

Business

Nexalin Technology Provides 2022 Year-End Business Update

Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today provided a business update for the year ended December 31, 2022.

March 27, 2023
·
9 min read
Business

Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update

Gamida Cell Ltd. today provided a business update and reported financial results for the year ended December 31, 2022.

March 27, 2023
·
18 min read
Business

Seismic Therapeutic Appoints Melanie Manning as Chief People Officer

Seismic Therapeutic, Inc. announced today that Melanie Manning has joined the company as Chief People Officer.

March 27, 2023
·
3 min read
Business

STALICLA and Firefly Neuroscience enter Partnership Agreement for the Development of Electroencephalogram (EEG) as a Biomarker for Subgroups of Patients with ASD

STALICLA and Firefly Neuroscience today announced a partnership to further validate EEG-based biomarkers in biologically enriched subgroups of patients with Autism Spectrum Disorder (ASD).

March 27, 2023
·
5 min read
Deals

Todos Medical Begins Trading on the OTC Pink Marketplace

Todos Medical, Ltd. today announced that its Ordinary shares will begin trading on the OTC Pink marketplace beginning on March 27, 2023 as a result of the Company’s closing bid price falling below $0.001 for 5 consecutive trading days, from March 20, 2023 through March 24, 2023.

March 27, 2023
·
4 min read
Business

Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today provided Company updates and reported consolidated financial results for the year ended December 31, 2022.

March 27, 2023
·
21 min read
Biotech Bay

Cytokinetics Releases Inaugural Corporate Responsibility Report

Cytokinetics, Incorporated announced the release of its inaugural Corporate Responsibility Report, outlining the Company’s commitment to social and environmental responsibility, ethics and governance and patient and community engagement.

March 27, 2023
·
4 min read
Olink publishes 2022 annual report

Olink Holding AB announced that the Annual Report for 2022 is now available on the Company’s website.

March 27, 2023
·
1 min read
Business

Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Reneo Pharmaceuticals, Inc. today reported financial results for the quarter and year ended December 31, 2022 and provided a business update.

March 27, 2023
·
9 min read
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test

bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced that it has received Health Canada authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test, allowing its immediate entry into the Canadian market.

March 27, 2023
·
6 min read